Drugs / Exosome-Containing Liquid
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07703969 | Sep → Dec 2026 expected | irritant dermatitis | West Kazakhstan Marat Ospanov Medical University | Not yet recruiting | No outcome recorded |
| Phase 1 | NCT07707986 | Sep → Dec 2026 expected | irritant dermatitis | West Kazakhstan Marat Ospanov Medical University | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Exosome-Containing Liquid | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07703969 ↗ |
| Modality | Other / unclassified | “exosome-enriched extracellular vesicles” NCT07703969 ↗ |
| Route | Topical | “The liquid will be applied topically to a small defined area of intact skin” NCT07703969 ↗ |